Overview
Portfolio
More
Oxfordinvestmentconsultants
Oxford, United Kingdom
Backing founders commercialising scientific research from Oxford University and other UK research institutions, with investments ranging from seed to Series C.
Portfolio
31+
Employees
10+
Founded
2015
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
United Kingdom
Sources
Oxfordinvestmentconsultants
Backing founders commercialising scientific research from Oxford University and other UK research institutions, with investments ranging from seed to Series C.
Portfolio
31+
Employees
10+
Founded
2015
AUM
N/A
Stages
No stages listed
Industries
No industries listedGeographic scope
United Kingdom
Sources
Showing 24 of 25 matched portfolio companies
AI Tech Solutions develops AI-driven digital tools that enhance productivity and create engaging entertainment experiences. The company focuses on improving operational efficiency for businesses while providing customized support for successful AI project implementation.
BibliU offers a Learning Enablement platform that automates the workflow for digital textbooks and courseware, providing institutions with access to essential learning materials at 30-50% lower costs than traditional methods. This solution ensures that all students have immediate access to required content, enhancing educational equity and improving student outcomes.
Funding: $1.4M
Rough estimate of the amount of funding raised
Wealth Club
Wealth Club
Funding: $1.4M
Rough estimate of the amount of funding raised
Biofidelity has developed molecular biology technologies, Aspyre® and Enspyre®, that enable local and cost-effective genomic analysis for cancer diagnosis and treatment selection. This approach addresses the challenge of limited access to biomarker testing, ensuring more patients receive timely and appropriate targeted therapies.
Funding: $61.4M
Rough estimate of the amount of funding raised
Funding: $61.4M
Rough estimate of the amount of funding raised
Brill Power provides a Battery Intelligence Platform that integrates battery management, chemistry-agnostic operating systems, and connected analytics. This platform enhances the longevity, performance, and sustainability of batteries used in electric vehicles and stationary energy storage. The technology aims to replace legacy battery management systems to unlock greater efficiency and lower lifetime costs for energy storage applications.
Funding: $21.4M
Rough estimate of the amount of funding raised
Funding: $21.4M
Rough estimate of the amount of funding raised
Caristo Diagnostics utilizes CaRi-Heart® technology to detect hidden inflammation in coronary arteries, enabling early diagnosis of heart diseases, stroke, and diabetes. This platform enhances preventive screening and optimizes treatment planning by providing individualized risk scores based on advanced imaging analysis.
Funding: $30.5M
Rough estimate of the amount of funding raised
HeartX
HeartX
Funding: $30.5M
Rough estimate of the amount of funding raised
Cove is a co‑living platform that offers fully furnished private rooms in curated Singapore properties, with utilities, high‑speed Wi‑Fi, housekeeping and maintenance bundled into a single monthly price. Users can book instantly online for flexible stay lengths—monthly or nightly—and filter listings by location, budget and amenities, while enjoying community events and shared spaces that foster a sense of belonging.
The startup has developed a fluid-shaping technology that replaces traditional microtiter plates with a microscale system for single-cell cloning, allowing researchers to expose cells to relevant experimental conditions. This technology enables multiple users to conduct simultaneous experiments efficiently, addressing the limitations of current cloning methods.
Funding: $11.8M
Rough estimate of the amount of funding raised
Funding: $11.8M
Rough estimate of the amount of funding raised
Develops affordable hyperspectral imaging cameras that capture spectral data at video rates, enabling applications in agriculture, healthcare, remote sensing, and colorimetry. These systems provide detailed insights beyond visible light, improving decision-making by revealing hidden information such as crop health, tissue types, and product appearance under varying lighting conditions.
Funding: $32.1M
Rough estimate of the amount of funding raised
Funding: $32.1M
Rough estimate of the amount of funding raised
Moment Technologies develops a software development tool that integrates various control, monitoring, and command-line tools into a single user interface, enabling infrastructure and platform teams to streamline their workflows. The platform facilitates the creation of interactive documentation using Git and Markdown, enhancing developer onboarding and release management while improving collaboration.
Funding: $15.0M
Rough estimate of the amount of funding raised
Funding: $15.0M
Rough estimate of the amount of funding raised
Nano Corp provides a deep network observability platform that enables full visibility of hybrid networks by analyzing every packet across all devices, identifying unknown devices and suspicious patterns. Their AI-powered on-premise detection solution enhances threat detection capabilities without sharing metadata, addressing the limitations of traditional EDR and XDR systems.
20+
1K+Approximate amount of employees
Funding: $4.4M
Rough estimate of the amount of funding raised
Giesecke+Devrient Ventures
Giesecke+Devrient Ventures
Funding: $4.4M
Rough estimate of the amount of funding raised
The startup has developed a peptide identification and optimization platform that utilizes peptide bead display and ribonucleic acid display technologies to discover and present novel natural peptides. This platform enables clients to efficiently identify therapeutic candidates through high-throughput affinity and functional screening, addressing the need for biologically relevant peptide leads in drug development.
Funding: $17.2M
Rough estimate of the amount of funding raised
Funding: $17.2M
Rough estimate of the amount of funding raised
Provides a clear aligner system combining FDA-cleared night-only wear NiTime Aligners™ and stain-resistant Bright Aligners™ to straighten and whiten teeth simultaneously. This approach offers a discreet, comfortable, and efficient alternative to traditional braces, treating various orthodontic issues while allowing patients to eat, drink, and speak without restrictions during the day.
Funding: $17.1M
Rough estimate of the amount of funding raised
SignalFire
SignalFire
Funding: $17.1M
Rough estimate of the amount of funding raised
Provides portable, lab-quality diagnostic testing through a single, low-cost instrument that integrates microfluidic sample preparation and electrochemical biosensing. This technology enables accurate, multiplexed testing in diverse settings like emergency departments, doctor’s offices, and retail pharmacies, addressing the need for accessible and efficient healthcare diagnostics.
Funding: $85.0M
Rough estimate of the amount of funding raised
Funding: $85.0M
Rough estimate of the amount of funding raised
Provides an API-driven authorization service that enables developers to implement role-based (RBAC), relationship-based (ReBAC), and attribute-based (ABAC) access control without overhauling existing application architectures. By generating SQL filters and authorizing locally against existing databases, it reduces integration time, eliminates syncing issues, and supports high-performance, scalable permission management across cloud, hybrid, and on-prem environments.
Funding: $26.0M
Rough estimate of the amount of funding raised
Funding: $26.0M
Rough estimate of the amount of funding raised
Ox provides a Human-Centered Automation platform that integrates with existing warehouse systems to create AI-powered workflows, enhancing frontline productivity and reducing training times. By focusing on the operator experience, Ox addresses the challenge of inefficient manual processes in supply chain operations, enabling companies to optimize their workforce and improve operational efficiency.
The startup has developed a brain biomarker technology that utilizes magnetic resonance imaging to measure cortical disarray, providing an index of cellular circuit health in the brain. This technology enables early and differential diagnosis of cognitive diseases, particularly Alzheimer's, allowing for timely intervention and treatment.
Funding: $8.9M
Rough estimate of the amount of funding raised
Funding: $8.9M
Rough estimate of the amount of funding raised
Oxford Endovascular is developing OxiFlow™, a next-generation flow diverter that redirects blood flow away from intracranial aneurysms at risk of rupture, enhancing placement accuracy and safety. This technology addresses the critical issue of brain hemorrhage, which affects 1 in 50 individuals, by making more patients eligible for effective treatment.
Funding: $25.7M
Rough estimate of the amount of funding raised
Parkwalk Advisors
Parkwalk Advisors
Funding: $25.7M
Rough estimate of the amount of funding raised
The startup develops lightweight pressure control equipment, including gas and fluid pressure regulators, to enhance the reliability of conventional valve systems. Their technology simplifies water distribution systems, ensuring consistent potable water supply while meeting stringent water quality and leakage control standards, ultimately reducing operational costs for energy, water, and process industries.
Funding: $54.2M
Rough estimate of the amount of funding raised
BP VenturesEnergy Impact Partners
BP VenturesEnergy Impact Partners
Funding: $54.2M
Rough estimate of the amount of funding raised
Oxford PV develops perovskite-on-silicon tandem solar cells that significantly increase energy conversion efficiency beyond conventional silicon limits. This technology integrates with existing manufacturing processes to deliver higher power output per area, reducing the levelized cost of energy for solar installations.
Oxford Quantum Circuits develops enterprise-ready quantum computing solutions that utilize hybrid computation to tackle complex problems beyond the capabilities of classical machines. Their technology enables businesses to access quantum capabilities securely and reliably, facilitating breakthroughs in various industries.
Funding: $100.0M
Rough estimate of the amount of funding raised
SBI Investment
SBI Investment
Funding: $100.0M
Rough estimate of the amount of funding raised
Salú provides a digital platform that integrates occupational health and safety management with human resources systems, automating compliance with legal requirements and streamlining health examinations and safety training. By managing over 350 clients and 150,000 lives, Salú enhances workplace well-being and reduces administrative burdens through real-time health data analytics and a network of over 1,200 clinics across Brazil.
Funding: $2.4M
Rough estimate of the amount of funding raised
Funding: $2.4M
Rough estimate of the amount of funding raised
SpyBiotech is a clinical-stage biotechnology company utilizing its proprietary protein superglue technology, SpyTag/SpyCatcher, to develop vaccines against infectious diseases and cancer. The company focuses on creating effective vaccines for conditions like cytomegalovirus, which currently lacks adequate prevention and treatment options.
Funding: $39.9M
Rough estimate of the amount of funding raised
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation
Funding: $39.9M
Rough estimate of the amount of funding raised
TakeIt.co provides a secure platform for buying and leasing domain names, ensuring safe transactions and fast transfers through streamlined processes. The service addresses the complexities and risks associated with domain acquisition, making it easier for users to navigate the marketplace.
T-Cypher Bio develops T-cell receptor-based therapeutics that utilize proprietary target screening libraries to identify functionally defined T-cell clones from disease tissues, specifically for solid tumors and other immune-mediated diseases. This approach enables healthcare providers to create tailored cell therapies that address the limitations of existing cancer treatments by targeting a broader range of tumor-specific antigens.
Funding: $24.3M
Rough estimate of the amount of funding raised
Oxford Science Enterprises
Oxford Science Enterprises
Funding: $24.3M
Rough estimate of the amount of funding raised
Showing 6 of 6 unmatched portfolio companies
Mind Foundry
No website provided
We don't have a full profile for this company yet.
Oxehealth
No website provided
We don't have a full profile for this company yet.
Navenio
No website provided
We don't have a full profile for this company yet.
Salience Labs
No website provided
We don't have a full profile for this company yet.
Diffblue
No website provided
We don't have a full profile for this company yet.